References
- He Y F, Wei W, Sun Z M, Ji C S, Wang G, Chen M P, et al. Fatal lactic acidosis and hypoglycemia in a patient with relapsed natural killer/T-cell lymphoma. Adv Ther 2007; 24: 505–509
- Di Comite G, Dagna L, Piatti P M, Monti L D, Tantardini F, Praderio L. Hypoglycaemia and lactic acidosis in a MALT non Hodgkin's lymphoma. Leuk Lymphoma 2002; 43: 1341–1342
- Dogan E, Erkoc R, Sayarlioglou H, Alici S, Dilek I, Alici O. Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin's lymphoma: a case report. Adv Ther 2005; 22: 443–446
- Durig J, Fiedler W, de Wit M, Steffen M, Hossfeld D K. Lactic acidosis and hypoglycemia in a patient with high grade non-Hodgkin's lymphoma and elevated circulating TNF-α. Ann Hematol 1996; 72: 97–99
- Braund W J, Naylor B A, Williamson D H, Buley I D, Clark A, Chapel H M, et al. Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease. Lancet 1987; 1: 237–240
- Kulkarni A, Zlabek J, Farnen J, Capla R. Recurrent hypoglycemia and hypothermia in a patient with Hodgkin's disease. Haematologica 2006; 91: 137–138
- Glasheen J J, Sorensen D M. Burkitt's lymphoma presenting with lactic acidosis and hypoglycaemia – a case presentation. Leuk Lymphoma 2005; 46: 281–283
- Nauck M A, Reinecke M, Perren A, Frystyk J, Berishvili G, Zwimpfer C, et al. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab 2007; 92: 1600–1605
- Daughaday W H, Emanuele M A, Brooks M H, Barbato A L, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988; 319: 1434–1440
- Baxter R. The role of insulin-like growth factors and their binding proteins in tumor hypoglycaemia. Horm Res 1996; 46: 195–201
- Daughaday W H, Trived B, Baxter R C. Serum ‘big insulin-like growth factor II’ from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 1993; 90: 5823–5827
- Zachariah S, Brackenridge A, Shojaee F-Moradie, Cumuncho-Hubner C, Umpleby A M, Russel-Jones D. The mechanism of non-islet hypoglycaemia caused by tumour-produced IGF-II. Clin Endocrinol (Oxf) 2007; 67: 637–641
- Ben-Chetrit E, Melmed R N. Recurrent hypoglycemia in multiple myeloma: a case of Munchausen syndrome by proxy in an elderly patient. J Intern Med 1998; 244: 175–178
- Perry R R, Vinik A I. Clinical review 72: diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab 1995; 80: 2273–2278
- Uchigata Y, Hirata Y. Insulin autoimmune syndrome (IAS, Hirata disease). Ann Med Interne (Paris) 1999; 150: 245–253
- Halsall D J, Mangi M, Soos M, Fahie-Wilson M N, Wark G, Mainwaring-Burton R, et al. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-κ myeloma. J Clin Endocrinol Metab 2007; 92: 2013–2016